Takeda posts strong first half FY2024 results

Japanese pharma major Takeda (TYO: 4502) today announced earnings results for the first half of fiscal year 2024 (six months ended September 30, 2024), with continued momentum in its Growth & Launch Products driving growth.

Revenues grew 13.4% to 2,384 billion yen ($15.6 billion), with operating profit rising 194% to 350.6 billion yen, and net profit leaping 352.8% to 187.3 billion yen. Earning per share were 119 yen, compared 27 yen in the year earlier six months.

Takeda raised its full-year operating profit guidance to 265 billion yen from 225 billion, citing a stronger than expected first-half performance and updated currency assumptions. This reflects stronger than anticipated first-half performance (including milder than anticipated generic erosion of Vyvanse (lisdexamfetamine dimesylate) in the USA) and revised foreign exchange assumptions.